丹参酮ⅡA磺酸钠治疗急性脑梗死临床疗效观察

目的：评价丹参酮ⅡA磺酸钠治疗急性脑梗死临床疗效。方法：选择我院2009年7月～2012年10月收治的急性脑梗死患者。80例为对照组，采用常规方法治疗。另选择同期收治的80例急性脑梗死患者为观察组，在常规治疗的同时加用丹参酮ⅡA磺酸钠治疗。对比2组的临床疗效及治疗前后神经功能缺损和日常生活能力的变化情况。结果：经治疗后，其中观察组总有效率为93．75％，对照组为77．50％，2组对照差异有统计学意义（P＜O．01）。而治疗后2组神经功能缺损评分以及日常生活能力评分比较观察组均优于对照组，差异有统计学意义（P＜0．01）。结论：将丹参酮ⅡA磺酸钠用于急性脑梗死临床治疗，能取得显著疗效，值得临床推广应用。

Clinical Efficacy of Tanshinone Injection in Treatment of Acute Cerebral Infarction

Objective：To evaluate clinical efficacy of Tanshinone injection in the treatment of acute cerebral infarction .Methods：To-tally 8O cases of acute cerebral infarction admitted to hospital from July 2009 to September 2012 as the control group using conventional methods for treatment.Another selected the same period 8O cases were admitted with acute cerebral infarction 80 cases as the observation group.while in the conventional treatment plus Tanshinone injection .Clinical efficacy before and after treatment ,neurological deficits and activities of daily living ,changes in the two groups were compared .Results：After treatment , the total effective rate was 93 .75%in obser-vation group,77.50%in the control group,the difference was statistically significant （P〈0.01）.After treatment,the nerve function defect score decreased significantly than before ,while the observation group decreased more significantly than the control group （P〈0.01）;Ac-tivities of daily living scores after treatment compared with before the treatmen were obviously increase , the observation group was better than the control group（P〈0.01）.After treatment,the difference was statistically significant .Conclusion：The clinical efficacy of Tanshi-none injection in treatment of acute cerebral infarction can significantly improve the neurological dysfunction in patients and improve the daily living skills ,So that the patient＇s quality of life were improved .